King Charles III’s brief hospital stay reminds UK that monarch is still a cancer patient
Charles took part in 372 public engagements last year, even after stepping aside for almost three months because of cancer ...
New Guidelines Upped Lung Cancer Screenings, But Gaps Remain
People can access free or low-cost scans, “but screening is not a one-time deal. Patients should get a scan annually, and ...
J&J Passes AstraZeneca in Lung Cancer Drug Race — For Now
Johnson & Johnson has pulled ahead of rival AstraZeneca Plc in a race to dominate the blockbuster market for lung cancer ...
CURE4d
First Patient Dosed with Efti in Phase 3 Trial for Non-Small Cell Lung Cancer
The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...
Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer
SAN ANTONIO, March 26, 2025--bioAffinity Technologies' CyPath Lung test uncovered a hidden second primary lung cancer in a patient who had been treated for lung cancer earlier.
Physician's Weekly3d
Assessing Nutritional Status Vital in Patients With Lung Cancer
Research assessing the nutritional status and impact of interventions for patients with lung cancer found that most exhibit ...
Fierce Biotech1d
BioNTech shows off lung cancer survival data behind phase 3 push for red-hot bispecific
BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...
ThePrint on MSN1d
PGIMER report bats for new-age targeted lung cancer therapies to be included in AB-PMJAY
Report commissioned by govt analysed cost-effectiveness of 2 medicines, comparing them to to chemo in patients with newly ...
KATC2d
Ochsner Lafayette General first to offer new lung cancer treatment
Ochsner Lafayette General Medical Center performed its first procedure with the Ion robotic-assisted bronchoscopy system; ...
Increased use of chest X-rays linked to earlier lung cancer diagnosis and improved survival
A groundbreaking study has revealed a significant link between the frequency of chest X-ray referrals from GPs and earlier ...
Targeted Oncology2d
Zongertinib Shows Antitumor Activity in Patients With HER2-Altered Tumors
The TKI zongertinib is currently being reviewed by the FDA for a potential approval for patients with HER2 mutation–positive ...
First Patient Dosed in Immutep’s TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer
First patient safely dosed at Calvary Mater Newcastle Hospital in Australia, marking a significant milestone for ...